IMVTFinancial ServicesMid-Cap

Immunovant, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Immunovant, Inc. (IMVT), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are IMVT insiders buying or selling?

Immunovant, Inc. insiders reported 25 open-market buys ($784.9M) and 169 sells ($41.2M) across 194 Form 4 filings — a net buying position of $743.7M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 6, 2026)

Total Form 4 filings
194
SEC EDGAR
Insider filers
19
Insider buys (25)
$784.9M
Insider sells (169)
$41.2M

Insider sentiment

Net buying

Net insider flow of $743.7M in net buying.

Recent IMVT insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 6, 2026Eric VenkerChief Executive OfficerSale3.1K$38.48$119.0K
Jun 26, 2026Melanie GloriaChief Operating OfficerSale17.7K$38.31$678.6K
Jun 26, 2026Jay S StoutChief Technology OfficerSale40.0K$38.31$1.5M
Jun 26, 2026Tuyl Christopher VanChief Legal OfficerSale17.8K$38.31$682.9K
Jun 26, 2026Tiago GiraoChief Financial OfficerSale10.0K$38.46$384.6K
Jun 26, 2026Atul PandeDirectorSale1.5K$38.01$57.0K
Jun 22, 2026Tuyl Christopher VanChief Legal OfficerSale2.6K$35.39$93.2K
Jun 16, 2026Atul PandeDirectorSale1.5K$34.02$51.0K
May 29, 2026Andrew J. FromkinDirectorSale222.0K$33.51$7.4M
May 22, 2026Melanie GloriaChief Operating OfficerSale3.1K$32.45$101.1K
May 21, 2026Atul PandeDirectorSale6.0K$32.00$192.0K
May 1, 2026Robert Graham SusmanDirectorSale2.5K$27.17$68.0K
Apr 24, 2026Tiago GiraoChief Financial OfficerSale25.8K$29.62$763.0K
Apr 24, 2026Jay S StoutChief Technology OfficerSale2.8K$29.62$81.6K
Apr 10, 2026Tuyl Christopher VanChief Legal OfficerSale5.2K$24.83$128.2K
Apr 10, 2026Melanie GloriaChief Operating OfficerSale8.7K$24.83$216.6K
Apr 10, 2026Jay S StoutChief Technology OfficerSale10.1K$24.83$251.6K
Apr 3, 2026Eric VenkerChief Executive OfficerSale14.2K$24.10$342.9K
Mar 20, 2026Tuyl Christopher VanChief Legal OfficerSale2.9K$24.97$71.8K
Feb 27, 2026Melanie GloriaChief Operating OfficerSale3.2K$27.85$90.2K
Jan 23, 2026Jay S StoutChief Technology OfficerSale2.0K$26.03$51.5K
Jan 9, 2026Jay S StoutChief Technology OfficerSale1.2K$26.53$31.9K
Dec 19, 2025Tuyl Christopher VanChief Legal OfficerSale10.8K$26.91$290.9K
Dec 12, 2025Roivant Sciences Ltd.Director, 10% OwnerPurchase16.7M$21.00$350.0M
Dec 3, 2025Andrew J. FromkinDirectorSale22.2K$23.25$517.2K

Showing the 25 most recent of 194 Form 4 filings for Immunovant, Inc..

Most active IMVT insiders

  • Peter Salzmann33 filings
  • Eva Renee Barnett24 filings
  • Julia G. Butchko24 filings
  • William L. Macias21 filings
  • Jay S Stout15 filings

Ask anything about IMVT insider activity

Use Trabud's AI agent to query Immunovant, Inc.'s Form 4 history in plain English — "Show me IMVT CEO purchases this year" or compare it against any other ticker.

Open the AI agent

IMVT insider trading FAQ

Are Immunovant, Inc. insiders buying or selling?

Across 194 SEC Form 4 filings, Immunovant, Inc. (IMVT) insiders reported 25 open-market purchases totaling $784.9M and 169 sales totaling $41.2M. That is a net buying position of $743.7M.

How many insiders trade IMVT stock?

19 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Immunovant, Inc.. The most recent filing was accepted on Jul 6, 2026.

Where does Trabud get IMVT insider trading data?

All IMVT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content